Xeris Biopharma Holdings
(NASDAQ:XERS)
$1.7601
-0.1199[-6.38%]
At close: May 10
$1.7601
0[0.00%]
After Hours: 7:27PM EDT
Q1 2024 Earnings were released on Thu May 9th, before the market open
The most recent conference call was at 8:30 AM, 2 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Xeris Biopharma Holdings Stock (NASDAQ:XERS), Quotes and News Summary

Xeris Biopharma Holdings Stock (NASDAQ: XERS) stock price, news, charts, stock research, profile.

Open$1.910
Close$1.760
Volume / Avg.1.940M / 1.852M
Day Range1.730 - 1.910
52 Wk Range1.460 - 3.260
Market Cap$260.941M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
38
Short Interest
6.18%
Days to Cover6.72

Recent News

Why Are Xeris Biopharma Shares Moving Monday?
Xeris Biopharma shares are up Monday after the company announced an exclusive worldwide collaboration and license agreement with Beta Bionics. Xeris said it will work with Beta Bionics to develop and release a glucagon product that will utilize the company's XeriSol technology and Beta Bionic's pump systems.
Dylan Berman
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.
Avi Kapoor
Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose during Thursday’s session following better-than-expected quarterly results.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Nov 23
2
Mar
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
XERS
AVIR

FAQ

Q

How do I buy Xeris Biopharma Holdings (XERS) stock?

A

You can purchase shares of Xeris Biopharma Holdings (NASDAQ: XERS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Xeris Biopharma Holdings's (XERS) competitors?

A

Other companies in Xeris Biopharma Holdings’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Terns Pharma (NASDAQ:TERN), Rani Therapeutics Hldgs (NASDAQ:RANI) and Aquestive Therapeutics (NASDAQ:AQST).

Q

What is the target price for Xeris Biopharma Holdings (XERS) stock?

A

The latest price target for Xeris Biopharma Holdings (NASDAQ: XERS) was reported by Piper Sandler on Friday, May 10, 2024. The analyst firm set a price target for 3.00 expecting XERS to rise to within 12 months (a possible 70.44% upside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Xeris Biopharma Holdings (XERS)?

A

The stock price for Xeris Biopharma Holdings (NASDAQ: XERS) is $1.7601 last updated May 10, 2024 at 7:27 PM EDT.

Q

Does Xeris Biopharma Holdings (XERS) pay a dividend?

A

There are no upcoming dividends for Xeris Biopharma Holdings.

Q

When is Xeris Biopharma Holdings (NASDAQ:XERS) reporting earnings?

A

Xeris Biopharma Holdings’s Q2 earnings are confirmed for Tuesday, August 6, 2024.

Q

Is Xeris Biopharma Holdings (XERS) going to split?

A

There is no upcoming split for Xeris Biopharma Holdings.

Q

What sector and industry does Xeris Biopharma Holdings (XERS) operate in?

A

Xeris Biopharma Holdings is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch